Updates

Incremental Progress Not Enough To Handle Biological Emergencies, Let Alone Catastrophic Events

While acknowledging some positive efforts over the past year by the White House and Congress, the bipartisan Blue Ribbon Study Panel on Biodefense says the incremental progress is not enough to defend against biological emergencies, let alone catastrophic events. Their report states that while the biological threat is real and continues to grow, our nation remains woefully under-prepared for dangerous biological incidents.

Rural Volunteer Fire Departments Face Specific Challenges

In a September article, the Department of Homeland Security Science and Technology (S&T) Directorate asked if rural volunteer fire departments have unique needs, and if so, what S&T’s First Responders Group might do to address them. The volunteer firefighter community responded passionately with detailed emails and posts, which are detailed here.

S&T Releases New Incident Management Planning Tool for First Responders

The Department of Homeland Security Science and Technology Directorate Explosives Division has funded research at the Oak Ridge National Laboratory to continue development of the Incident Management Preparedness and Coordination Toolkit (IMPACT), a geospatial tool designed to enhance situational awareness, communication, and collaboration during and for security events.

Burn Saver Thermal Sensor Provides Warning for Firefighter Safety

The Department of Homeland Security Science and Technology Directorate’s First Responders Group (FRG) is working to provide firefighters with a timely warning system that PPE failure is imminent. FRG is working with TDA Research, Inc. to develop the Burn Saver Thermal Sensor, a battery-powered device that will be carried by firefighters and detects thermal changes in their operating environments.

DHS S&T Transition to Practice Program Transitions Eighth Cybersecurity Technology for Commercialization

The Department of Homeland Security Science and Technology announced the eighth cybersecurity technology transitioning to commercialization as a part of its Cyber Security Division’s Transition to Practice program. ZeroPoint, an exploit detection and analytics tool focuses on analyzing documents, email, web content and server traffic for potentially hazardous content known as exploit payloads.

PathSensors Launches Low Cost, High Speed Anthrax and BioThreat Detection Solution for Mail Security Screening

Baltimore biotech firm, PathSensors Inc., announced the launch of its new Bioflash MailGuard™ mail security screening solution. The Bioflash MailGuard™ system provides a fast, highly accurate, easy to use and low-cost threat detection solution for government and commercial mail room operations that need to screen mail and packages for potential threats such as anthrax.

Earthquake Faults Are Smarter Than We Usually Think

A Northwestern University research team has developed a model that shows that earthquake clusters can occur on faults with long-term memory. The memory comes from the fact that the earthquake did not release all the strain that built up on the fault over time, so some strain remains after a big earthquake and can cause another.

Pluristem’s PLX-R18 Advances Into Second Cohort of Dose Selection Study for Treatment of Acute Radiation Syndrome

Pluristem Therapeutics Inc. announced a milestone in its development program for PLX-R18, which is being evaluated as a medical countermeasure in the treatment of the hematologic components of Acute Radiation Syndrome (ARS) by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH).

NAMRU-6 Researcher Shows What Next Generation Sequencing Technologies Can Do

Mariana Leguia, Ph.D, head of the Genomics and Pathogen Discovery Unit at the U.S. Naval Medical Research Unit No. 6 (NAMRU-6) in Lima, Peru, provides insight on how next generation sequencing technologies can be used to advance public health research and pathogen detection.

Rutgers Receives $19 Million to Develop Drugs to Treat Chemical Weapons Attacks

The National Institutes of Health (NIH) has awarded Rutgers University a five-year grant for more than $19 million for research that would lead to the development of drugs to treat toxicity from chemical agents used in terrorist attacks.